“Eli Lilly CEO David Ricks said the pharmaceutical industry is working at “lightning speed” to develop a coronavirus treatment, and that Lilly is doing its part by collaborating with biotechnology firm AbCellera to create an antibody therapy to treat COVIDcampaign-pages/bispecifics/-19.”
Read full coverage on FOX Business.